Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.
2.

Time course of cytokine levels in sepsis.

Thijs LG, Hack CE.

Intensive Care Med. 1995 Nov;21 Suppl 2:S258-63. Review.

PMID:
8636533
3.

Sepsis and cytokines: current status.

Blackwell TS, Christman JW.

Br J Anaesth. 1996 Jul;77(1):110-7. Review.

4.

Interleukin-1, TNF alpha and their naturally occurring antagonists in sepsis.

Moldawer LL.

Blood Purif. 1993;11(2):128-33. Review.

PMID:
8274244
5.

[Physiopathology of severe sepsis].

Caille V, Bossi P, Grimaldi D, Vieillard-Baro A.

Presse Med. 2004 Feb 28;33(4):256-61; discussion 269. Review. French.

PMID:
15029017
6.

Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator.

Nakamura M, Oda S, Sadahiro T, Hirayama Y, Watanabe E, Tateishi Y, Nakada TA, Hirasawa H.

Contrib Nephrol. 2010;166:73-82. doi: 10.1159/000314855. Epub 2010 May 7. Review.

PMID:
20472994
7.

Cytokine and anti-cytokine strategies in inflammatory reaction modulation.

Delannoy I, Lekeux P, Miossec P.

Vet Res. 1993;24(6):449-67. Review.

PMID:
8111428
8.

Cytokines and anticytokines in the pathogenesis of sepsis.

van der Poll T, van Deventer SJ.

Infect Dis Clin North Am. 1999 Jun;13(2):413-26, ix. Review.

PMID:
10340175
9.

Continuous plasma filtration coupled with sorbents.

Tetta C, Cavaillon JM, Camussi G, Lonnemann FG, Brendolan A, Ronco C.

Kidney Int Suppl. 1998 May;66:S186-9. Review.

PMID:
9573601
10.

Role of cytokines as a double-edged sword in sepsis.

Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti PS, Nagarkatti M.

In Vivo. 2013 Nov-Dec;27(6):669-84. Review.

11.

Monocyte deactivation--rationale for a new therapeutic strategy in sepsis.

Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Müller JM, Döcke WD, Kox WJ.

Intensive Care Med. 1996 Oct;22 Suppl 4:S474-81. Review.

PMID:
8923092
12.

Inhibition of growth by pro-inflammatory cytokines: an integrated view.

Johnson RW.

J Anim Sci. 1997 May;75(5):1244-55. Review.

13.

The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment.

Haveman JW, Muller Kobold AC, Tervaert JW, van den Berg AP, Tulleken JE, Kallenberg CG, The TH.

Neth J Med. 1999 Sep;55(3):132-41. Review.

PMID:
10509072
14.

Cytokine cascade in sepsis.

Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D.

Scand J Infect Dis. 2003;35(9):535-44. Review.

PMID:
14620132
15.

Anticytokine therapies in sepsis.

Lowry SF.

New Horiz. 1993 Feb;1(1):120-6. Review.

PMID:
7922384
16.

[Diagnosis of sepsis based on the host response].

Matsumoto T.

Rinsho Byori. 1999 Jun;47(6):494-500. Review. Japanese.

PMID:
10434565
17.

Therapeutic implications of interleukin-10 in surgical disease.

Selzman CH, Shames BD, Miller SA, Pulido EJ, Meng X, McIntyre RC Jr, Harken AH.

Shock. 1998 Nov;10(5):309-18. Review.

PMID:
9840644
18.

Genetic variation in pro-inflammatory cytokines and meningococcal sepsis.

Deasy A, Read RC.

Curr Opin Infect Dis. 2010 Jun;23(3):255-8. Review.

PMID:
20419848
19.

Neonatal sepsis and inflammatory mediators.

Machado JR, Soave DF, da Silva MV, de Menezes LB, Etchebehere RM, Monteiro ML, dos Reis MA, Corrêa RR, Celes MR.

Mediators Inflamm. 2014;2014:269681. doi: 10.1155/2014/269681. Epub 2014 Dec 30. Review.

20.

Issues in the adjunct therapy of severe sepsis.

Verhoef J, Hustinx WM, Frasa H, Hoepelman AI.

J Antimicrob Chemother. 1996 Aug;38(2):167-82. Review.

Items per page

Supplemental Content

Write to the Help Desk